180 related articles for article (PubMed ID: 31238511)
1. Raman Evidence of p53-DBD Disorder Decrease upon Interaction with the Anticancer Protein Azurin.
Signorelli S; Cannistraro S; Bizzarri AR
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31238511
[TBL] [Abstract][Full Text] [Related]
2. Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin.
De Grandis V; Bizzarri AR; Cannistraro S
J Mol Recognit; 2007; 20(4):215-26. PubMed ID: 17703463
[TBL] [Abstract][Full Text] [Related]
3. Structural Characterization of the Intrinsically Disordered Protein p53 Using Raman Spectroscopy.
Signorelli S; Cannistraro S; Bizzarri AR
Appl Spectrosc; 2017 May; 71(5):823-832. PubMed ID: 27340212
[TBL] [Abstract][Full Text] [Related]
4. Structural characteristics of the hydrophobic patch of azurin and its interaction with p53: a site-directed spin labeling study.
Xu C; Yin J; Zhao B
Sci China Life Sci; 2010 Oct; 53(10):1181-8. PubMed ID: 20953940
[TBL] [Abstract][Full Text] [Related]
5. Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy.
Bizzarri AR; Santini S; Coppari E; Bucciantini M; Di Agostino S; Yamada T; Beattie CW; Cannistraro S
Int J Nanomedicine; 2011; 6():3011-9. PubMed ID: 22162658
[TBL] [Abstract][Full Text] [Related]
6. Does azurin bind to the transactivation domain of p53? A Trp phosphorescence study.
Gabellieri E; Bucciantini M; Stefani M; Cioni P
Biophys Chem; 2011 Dec; 159(2-3):287-93. PubMed ID: 21885181
[TBL] [Abstract][Full Text] [Related]
7. A combined atomic force microscopy imaging and docking study to investigate the complex between p53 DNA binding domain and Azurin.
Bizzarri AR; Di Agostino S; Andolfi L; Cannistraro S
J Mol Recognit; 2009; 22(6):506-15. PubMed ID: 19642109
[TBL] [Abstract][Full Text] [Related]
8. Modelling the interaction between the p53 DNA-binding domain and the p28 peptide fragment of Azurin.
Santini S; Bizzarri AR; Cannistraro S
J Mol Recognit; 2011; 24(6):1043-55. PubMed ID: 22038811
[TBL] [Abstract][Full Text] [Related]
9. The interaction of azurin and C-terminal domain of p53 is mediated by nucleic acids.
Xu C; Zhao Y; Zhao B
Arch Biochem Biophys; 2010 Nov; 503(2):223-9. PubMed ID: 20800053
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the anticancer p28 peptide with p53-DBD as studied by fluorescence, FRET, docking and MD simulations.
Bizzarri AR; Moscetti I; Cannistraro S
Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):342-350. PubMed ID: 30419285
[TBL] [Abstract][Full Text] [Related]
11. Unique complex between bacterial azurin and tumor-suppressor protein p53.
Apiyo D; Wittung-Stafshede P
Biochem Biophys Res Commun; 2005 Jul; 332(4):965-8. PubMed ID: 15913547
[TBL] [Abstract][Full Text] [Related]
12. Modeling the interaction between the N-terminal domain of the tumor suppressor p53 and azurin.
Taranta M; Bizzarri AR; Cannistraro S
J Mol Recognit; 2009; 22(3):215-22. PubMed ID: 19140135
[TBL] [Abstract][Full Text] [Related]
13. p28, a first in class peptide inhibitor of cop1 binding to p53.
Yamada T; Christov K; Shilkaitis A; Bratescu L; Green A; Santini S; Bizzarri AR; Cannistraro S; Gupta TK; Beattie CW
Br J Cancer; 2013 Jun; 108(12):2495-504. PubMed ID: 23736031
[TBL] [Abstract][Full Text] [Related]
14. A nanotechnological, molecular-modeling, and immunological approach to study the interaction of the anti-tumorigenic peptide p28 with the p53 family of proteins.
Coppari E; Yamada T; Bizzarri AR; Beattie CW; Cannistraro S
Int J Nanomedicine; 2014; 9():1799-813. PubMed ID: 24748790
[TBL] [Abstract][Full Text] [Related]
15. Binding of Amphipathic Cell Penetrating Peptide p28 to Wild Type and Mutated p53 as studied by Raman, Atomic Force and Surface Plasmon Resonance spectroscopies.
Signorelli S; Santini S; Yamada T; Bizzarri AR; Beattie CW; Cannistraro S
Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):910-921. PubMed ID: 28126403
[TBL] [Abstract][Full Text] [Related]
16. Bacterial cupredoxin azurin and its interactions with the tumor suppressor protein p53.
Punj V; Das Gupta TK; Chakrabarty AM
Biochem Biophys Res Commun; 2003 Dec; 312(1):109-14. PubMed ID: 14630027
[No Abstract] [Full Text] [Related]
17. Complete sequential 1H and 15N nuclear magnetic resonance assignments and solution secondary structure of the blue copper protein azurin from Pseudomonas aeruginosa.
van de Kamp M; Canters GW; Wijmenga SS; Lommen A; Hilbers CW; Nar H; Messerschmidt A; Huber R
Biochemistry; 1992 Oct; 31(42):10194-207. PubMed ID: 1420141
[TBL] [Abstract][Full Text] [Related]
18. Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.
Krois AS; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11302-E11310. PubMed ID: 30420502
[TBL] [Abstract][Full Text] [Related]
19. Probing the interaction between p53 and the bacterial protein azurin by single molecule force spectroscopy.
Taranta M; Bizzarri AR; Cannistraro S
J Mol Recognit; 2008; 21(1):63-70. PubMed ID: 18247358
[TBL] [Abstract][Full Text] [Related]
20. R248Q mutation--Beyond p53-DNA binding.
Ng JW; Lama D; Lukman S; Lane DP; Verma CS; Sim AY
Proteins; 2015 Dec; 83(12):2240-50. PubMed ID: 26442703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]